1. Home
  2. ADMA vs KNF Comparison

ADMA vs KNF Comparison

Compare ADMA & KNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • KNF
  • Stock Information
  • Founded
  • ADMA 2004
  • KNF 1917
  • Country
  • ADMA United States
  • KNF United States
  • Employees
  • ADMA N/A
  • KNF N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • KNF
  • Sector
  • ADMA Health Care
  • KNF
  • Exchange
  • ADMA Nasdaq
  • KNF Nasdaq
  • Market Cap
  • ADMA 5.1B
  • KNF 5.3B
  • IPO Year
  • ADMA N/A
  • KNF N/A
  • Fundamental
  • Price
  • ADMA $17.74
  • KNF $77.59
  • Analyst Decision
  • ADMA Strong Buy
  • KNF Strong Buy
  • Analyst Count
  • ADMA 4
  • KNF 6
  • Target Price
  • ADMA $24.25
  • KNF $117.17
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • KNF 551.0K
  • Earning Date
  • ADMA 08-07-2025
  • KNF 08-05-2025
  • Dividend Yield
  • ADMA N/A
  • KNF N/A
  • EPS Growth
  • ADMA N/A
  • KNF 1.95
  • EPS
  • ADMA 0.84
  • KNF 3.18
  • Revenue
  • ADMA $459,381,000.00
  • KNF $2,922,886,000.00
  • Revenue This Year
  • ADMA $23.35
  • KNF $15.00
  • Revenue Next Year
  • ADMA $27.67
  • KNF $7.17
  • P/E Ratio
  • ADMA $21.27
  • KNF $24.86
  • Revenue Growth
  • ADMA 62.23
  • KNF 2.48
  • 52 Week Low
  • ADMA $10.21
  • KNF $66.51
  • 52 Week High
  • ADMA $25.67
  • KNF $108.83
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 32.83
  • KNF 28.34
  • Support Level
  • ADMA $20.42
  • KNF $79.40
  • Resistance Level
  • ADMA $22.37
  • KNF $84.99
  • Average True Range (ATR)
  • ADMA 0.88
  • KNF 3.32
  • MACD
  • ADMA -0.28
  • KNF -1.54
  • Stochastic Oscillator
  • ADMA 1.07
  • KNF 3.51

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About KNF Knife Riv Holding Co.

Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.

Share on Social Networks: